| Accreditation Status: |
currently not accredited to ISO 17043 |
| Date Scheme started: |
Started 2026 |
| Clinical Applicability: |
Diagnosis and management of Addison’s disease and other autoimmune polyendocrine syndromes |
| Analytes: |
Anti-Adrenal Cortex and Anti-P450 C21—Hydroxylase (SER/067) |
| Units for Reporting: |
Qualitative responses or interpretation of quantitative results recorded as POSitive or NEGative. |
| Samples Distributed: |
Liquid format. Normal and pathological human serum |
| Number of Distributions per year: |
4 |
| Number of Samples per Distribution: |
2 |
| Frequency of Distributions: |
Every three months as outlined in the Distribution Schedule |
| Schedule of Analysis: |
Data entry is via the web for the submission of results. Data analysis commences 21 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics. |
| Data Analysis: |
Qualitative responses are assessed in relation to the designated response |
| Performance Scoring: |
MI scoring based on Consensus Designated Response |
| Criteria of Performance: |
TBC (Pilot scheme) |
| Persistent Poor Performance: |
TBC (Pilot scheme) |
